選択的Cox-2阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Selective Cox-2 Inhibitors Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C5102
• 出版社/出版日：GlobalInfoResearch / 2019年7月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、138ページ
• 納品方法：Eメール
• 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートは、選択的Cox-2阻害剤の世界市場について調べ、まとめました。種類別セグメントは、メロキシカム、セレコキシブ、エトリコキシブ、イムレコキシブ、エトドラク、パレコキシブ、その他等、用途別セグメントは、等に区分しました。選択的Cox-2阻害剤の世界市場概観、企業動向、企業別選択的Cox-2阻害剤シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・選択的Cox-2阻害剤の市場概観
・選択的Cox-2阻害剤の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・選択的Cox-2阻害剤の企業別販売動向、市場シェア、市場集中度、競争動向
・選択的Cox-2阻害剤の世界市場規模
・選択的Cox-2阻害剤の北米市場分析（アメリカ、カナダ、メキシコ等）
・選択的Cox-2阻害剤のアメリカ市場規模推移
・選択的Cox-2阻害剤のカナダ市場規模推移
・選択的Cox-2阻害剤のメキシコ市場規模推移
・選択的Cox-2阻害剤のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・選択的Cox-2阻害剤のドイツ市場規模推移
・選択的Cox-2阻害剤のイギリス市場規模推移
・選択的Cox-2阻害剤のロシア市場規模推移
・選択的Cox-2阻害剤のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・選択的Cox-2阻害剤の日本市場規模推移
・選択的Cox-2阻害剤の中国市場規模推移
・選択的Cox-2阻害剤の韓国市場規模推移
・選択的Cox-2阻害剤のインド市場規模推移
・選択的Cox-2阻害剤の東南アジア市場規模推移
・選択的Cox-2阻害剤の南米市場分析（ブラジル、アルゼンチン等）
・選択的Cox-2阻害剤の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・選択的Cox-2阻害剤の種類別分析/販売量、売上、市場シェア（メロキシカム、セレコキシブ、エトリコキシブ、イムレコキシブ、エトドラク、パレコキシブ、その他）
・選択的Cox-2阻害剤の用途別分析/市場規模（）
・選択的Cox-2阻害剤の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・選択的Cox-2阻害剤の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Selective Cox-2 Inhibitors market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Selective Cox-2 Inhibitors.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Selective Cox-2 Inhibitors market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Selective Cox-2 Inhibitors market by product type and applications/end industries.

Market Segment by Companies, this report covers
Boehringer-Ingelheim
TerSera Therapeutics
Iroko Pharmaceuticals
Apotex
Yung Shin Pharmaceutical
Breckenridge Pharmaceutical
Meda Pharmaceuticals
Cipla
Glenmark Pharmaceuticals
Teva
PuraCap Pharmaceutical
Almirall Limited
Lupin Pharmaceuticals
Aurobindo Pharma
Pfizer
Mylan
Shire Pharmaceuticals
Bayer
Novacap
Abbott
Geri-Care
Perrigo
Kopran
Merck
Hengrui pharmaceutical
Kelun Group
Qilu Pharmaceutical
Taro Pharmaceuticals

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Meloxicam
Celecoxib
Etoricoxib
Imrecoxib
Etodolac
Parecoxib
Other

Market Segment by Applications, can be divided into
Rheumatoid Arthritis
Osteoarthritis
Spondylosis Chronica Ankylopoietica
Other

レポート目次

Table of Contents

1 Selective Cox-2 Inhibitors Market Overview
1.1 Product Overview and Scope of Selective Cox-2 Inhibitors
1.2 Classification of Selective Cox-2 Inhibitors by Types
1.2.1 Global Selective Cox-2 Inhibitors Revenue Comparison by Types (2019-2024)
1.2.2 Global Selective Cox-2 Inhibitors Revenue Market Share by Types in 2018
1.2.3 Meloxicam
1.2.4 Celecoxib
1.2.5 Etoricoxib
1.2.6 Imrecoxib
1.2.7 Etodolac
1.2.8 Parecoxib
1.2.9 Other
1.3 Global Selective Cox-2 Inhibitors Market by Application
1.3.1 Global Selective Cox-2 Inhibitors Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Rheumatoid Arthritis
1.3.3 Osteoarthritis
1.3.4 Spondylosis Chronica Ankylopoietica
1.3.5 Other
1.4 Global Selective Cox-2 Inhibitors Market by Regions
1.4.1 Global Selective Cox-2 Inhibitors Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Selective Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Selective Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Selective Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Selective Cox-2 Inhibitors Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Selective Cox-2 Inhibitors Status and Prospect (2014-2024)
1.5 Global Market Size of Selective Cox-2 Inhibitors (2014-2024)
2 Manufacturers Profiles
2.1 Boehringer-Ingelheim
2.1.1 Business Overview
2.1.2 Selective Cox-2 Inhibitors Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Boehringer-Ingelheim Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.2 TerSera Therapeutics
2.2.1 Business Overview
2.2.2 Selective Cox-2 Inhibitors Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 TerSera Therapeutics Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.3 Iroko Pharmaceuticals
2.3.1 Business Overview
2.3.2 Selective Cox-2 Inhibitors Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Iroko Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.4 Apotex
2.4.1 Business Overview
2.4.2 Selective Cox-2 Inhibitors Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Apotex Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.5 Yung Shin Pharmaceutical
2.5.1 Business Overview
2.5.2 Selective Cox-2 Inhibitors Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.6 Breckenridge Pharmaceutical
2.6.1 Business Overview
2.6.2 Selective Cox-2 Inhibitors Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.7 Meda Pharmaceuticals
2.7.1 Business Overview
2.7.2 Selective Cox-2 Inhibitors Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Meda Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.8 Cipla
2.8.1 Business Overview
2.8.2 Selective Cox-2 Inhibitors Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.9 Glenmark Pharmaceuticals
2.9.1 Business Overview
2.9.2 Selective Cox-2 Inhibitors Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.10 Teva
2.10.1 Business Overview
2.10.2 Selective Cox-2 Inhibitors Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Teva Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.11 PuraCap Pharmaceutical
2.11.1 Business Overview
2.11.2 Selective Cox-2 Inhibitors Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 PuraCap Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.12 Almirall Limited
2.12.1 Business Overview
2.12.2 Selective Cox-2 Inhibitors Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Almirall Limited Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.13 Lupin Pharmaceuticals
2.13.1 Business Overview
2.13.2 Selective Cox-2 Inhibitors Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Lupin Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.14 Aurobindo Pharma
2.14.1 Business Overview
2.14.2 Selective Cox-2 Inhibitors Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Aurobindo Pharma Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.15 Pfizer
2.15.1 Business Overview
2.15.2 Selective Cox-2 Inhibitors Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Pfizer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.16 Mylan
2.16.1 Business Overview
2.16.2 Selective Cox-2 Inhibitors Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Mylan Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.17 Shire Pharmaceuticals
2.17.1 Business Overview
2.17.2 Selective Cox-2 Inhibitors Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Shire Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.18 Bayer
2.18.1 Business Overview
2.18.2 Selective Cox-2 Inhibitors Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bayer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.19 Novacap
2.19.1 Business Overview
2.19.2 Selective Cox-2 Inhibitors Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Novacap Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.20 Abbott
2.20.1 Business Overview
2.20.2 Selective Cox-2 Inhibitors Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Abbott Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.21 Geri-Care
2.21.1 Business Overview
2.2.2 Selective Cox-2 Inhibitors Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Geri-Care Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.22 Perrigo
2.22.1 Business Overview
2.22.2 Selective Cox-2 Inhibitors Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Perrigo Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.23 Kopran
2.23.1 Business Overview
2.23.2 Selective Cox-2 Inhibitors Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Kopran Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.24 Merck
2.24.1 Business Overview
2.24.2 Selective Cox-2 Inhibitors Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Merck Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.25 Hengrui pharmaceutical
2.25.1 Business Overview
2.25.2 Selective Cox-2 Inhibitors Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Hengrui pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.26 Kelun Group
2.26.1 Business Overview
2.26.2 Selective Cox-2 Inhibitors Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Kelun Group Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.27 Qilu Pharmaceutical
2.27.1 Business Overview
2.27.2 Selective Cox-2 Inhibitors Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Qilu Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
2.28 Taro Pharmaceuticals
2.28.1 Business Overview
2.28.2 Selective Cox-2 Inhibitors Type and Applications
2.28.2.1 Product A
2.28.2.2 Product B
2.28.3 Taro Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
3 Global Selective Cox-2 Inhibitors Market Competition, by Players
3.1 Global Selective Cox-2 Inhibitors Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Selective Cox-2 Inhibitors Players Market Share
3.2.2 Top 10 Selective Cox-2 Inhibitors Players Market Share
3.3 Market Competition Trend
4 Global Selective Cox-2 Inhibitors Market Size by Regions
4.1 Global Selective Cox-2 Inhibitors Revenue and Market Share by Regions
4.2 North America Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.3 Europe Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.5 South America Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5 North America Selective Cox-2 Inhibitors Revenue by Countries
5.1 North America Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
5.2 USA Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.3 Canada Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
5.4 Mexico Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6 Europe Selective Cox-2 Inhibitors Revenue by Countries
6.1 Europe Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
6.2 Germany Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.3 UK Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.4 France Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.5 Russia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
6.6 Italy Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Selective Cox-2 Inhibitors Revenue by Countries
7.1 Asia-Pacific Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
7.2 China Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.3 Japan Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.4 Korea Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.5 India Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8 South America Selective Cox-2 Inhibitors Revenue by Countries
8.1 South America Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
8.2 Brazil Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.3 Argentina Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
8.4 Colombia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Selective Cox-2 Inhibitors by Countries
9.1 Middle East and Africa Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
9.2 Saudi Arabia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.3 UAE Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.4 Egypt Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.5 Nigeria Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
9.6 South Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
10 Global Selective Cox-2 Inhibitors Market Segment by Type
10.1 Global Selective Cox-2 Inhibitors Revenue and Market Share by Type (2014-2019)
10.2 Global Selective Cox-2 Inhibitors Market Forecast by Type (2019-2024)
10.3 Meloxicam Revenue Growth Rate (2014-2024)
10.4 Celecoxib Revenue Growth Rate (2014-2024)
10.5 Etoricoxib Revenue Growth Rate (2014-2024)
10.6 Imrecoxib Revenue Growth Rate (2014-2024)
10.7 Etodolac Revenue Growth Rate (2014-2024)
10.8 Parecoxib Revenue Growth Rate (2014-2024)
10.9 Other Revenue Growth Rate (2014-2024)
11 Global Selective Cox-2 Inhibitors Market Segment by Application
11.1 Global Selective Cox-2 Inhibitors Revenue Market Share by Application (2014-2019)
11.2 Selective Cox-2 Inhibitors Market Forecast by Application (2019-2024)
11.3 Rheumatoid Arthritis Revenue Growth (2014-2019)
11.4 Osteoarthritis Revenue Growth (2014-2019)
11.5 Spondylosis Chronica Ankylopoietica Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Selective Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.1 Global Selective Cox-2 Inhibitors Market Size Forecast (2019-2024)
12.2 Global Selective Cox-2 Inhibitors Market Forecast by Regions (2019-2024)
12.3 North America Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.4 Europe Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.6 South America Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Selective Cox-2 Inhibitors Picture
Table Product Specifications of Selective Cox-2 Inhibitors
Table Global Selective Cox-2 Inhibitors and Revenue (Million USD) Market Split by Product Type
Figure Global Selective Cox-2 Inhibitors Revenue Market Share by Types in 2018
Figure Meloxicam Picture
Figure Celecoxib Picture
Figure Etoricoxib Picture
Figure Imrecoxib Picture
Figure Etodolac Picture
Figure Parecoxib Picture
Figure Other Picture
Table Global Selective Cox-2 Inhibitors Revenue (Million USD) by Application (2014-2024)
Figure Selective Cox-2 Inhibitors Revenue Market Share by Applications in 2018
Figure Rheumatoid Arthritis Picture
Figure Osteoarthritis Picture
Figure Spondylosis Chronica Ankylopoietica Picture
Figure Other Picture
Table Global Market Selective Cox-2 Inhibitors Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (2014-2024)
Table Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table Boehringer-Ingelheim Selective Cox-2 Inhibitors Type and Applications
Table Boehringer-Ingelheim Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table TerSera Therapeutics Selective Cox-2 Inhibitors Type and Applications
Table TerSera Therapeutics Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Iroko Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Iroko Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Selective Cox-2 Inhibitors Type and Applications
Table Apotex Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Yung Shin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Type and Applications
Table Yung Shin Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Breckenridge Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Type and Applications
Table Breckenridge Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Meda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Meda Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Meda Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Selective Cox-2 Inhibitors Type and Applications
Table Cipla Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Glenmark Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Selective Cox-2 Inhibitors Type and Applications
Table Teva Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table PuraCap Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table PuraCap Pharmaceutical Selective Cox-2 Inhibitors Type and Applications
Table PuraCap Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Almirall Limited Basic Information, Manufacturing Base and Competitors
Table Almirall Limited Selective Cox-2 Inhibitors Type and Applications
Table Almirall Limited Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Lupin Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Lupin Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table Aurobindo Pharma Selective Cox-2 Inhibitors Type and Applications
Table Aurobindo Pharma Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Selective Cox-2 Inhibitors Type and Applications
Table Pfizer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Selective Cox-2 Inhibitors Type and Applications
Table Mylan Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Shire Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Shire Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Shire Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Selective Cox-2 Inhibitors Type and Applications
Table Bayer Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Novacap Basic Information, Manufacturing Base and Competitors
Table Novacap Selective Cox-2 Inhibitors Type and Applications
Table Novacap Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Abbott Basic Information, Manufacturing Base and Competitors
Table Abbott Selective Cox-2 Inhibitors Type and Applications
Table Abbott Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Geri-Care Basic Information, Manufacturing Base and Competitors
Table Geri-Care Selective Cox-2 Inhibitors Type and Applications
Table Geri-Care Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Selective Cox-2 Inhibitors Type and Applications
Table Perrigo Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Kopran Basic Information, Manufacturing Base and Competitors
Table Kopran Selective Cox-2 Inhibitors Type and Applications
Table Kopran Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Selective Cox-2 Inhibitors Type and Applications
Table Merck Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Hengrui pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Hengrui pharmaceutical Selective Cox-2 Inhibitors Type and Applications
Table Hengrui pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Kelun Group Basic Information, Manufacturing Base and Competitors
Table Kelun Group Selective Cox-2 Inhibitors Type and Applications
Table Kelun Group Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Qilu Pharmaceutical Selective Cox-2 Inhibitors Type and Applications
Table Qilu Pharmaceutical Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Taro Pharmaceuticals Selective Cox-2 Inhibitors Type and Applications
Table Taro Pharmaceuticals Selective Cox-2 Inhibitors Revenue, Gross Margin and Market Share (2017-2018)
Table Global Selective Cox-2 Inhibitors Revenue (Million USD) by Players (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue Share by Players (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Share by Players in 2017
Figure Global Selective Cox-2 Inhibitors Revenue Share by Players in 2018
Figure Global Top 5 Players Selective Cox-2 Inhibitors Revenue Market Share in 2018
Figure Global Top 10 Players Selective Cox-2 Inhibitors Revenue Market Share in 2018
Figure Global Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue (Million USD) by Regions (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Market Share by Regions (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Market Share by Regions in 2018
Figure North America Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Europe Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South America Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table North America Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
Table North America Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure North America Selective Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure USA Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Canada Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Mexico Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Europe Selective Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Europe Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Europe Selective Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Germany Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UK Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure France Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Russia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Italy Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Selective Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Selective Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure China Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Japan Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Korea Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure India Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table South America Selective Cox-2 Inhibitors Revenue by Countries (2014-2019)
Table South America Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure South America Selective Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Brazil Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Argentina Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Colombia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Selective Cox-2 Inhibitors Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Share by Countries in 2018
Figure Saudi Arabia Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure UAE Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Egypt Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure Nigeria Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Figure South Africa Selective Cox-2 Inhibitors Revenue and Growth Rate (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue (Million USD) by Type (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Share by Type (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Share by Type in 2018
Table Global Selective Cox-2 Inhibitors Revenue Forecast by Type (2019-2024)
Figure Global Selective Cox-2 Inhibitors Market Share Forecast by Type (2019-2024)
Figure Global Meloxicam Revenue Growth Rate (2014-2019)
Figure Global Celecoxib Revenue Growth Rate (2014-2019)
Figure Global Etoricoxib Revenue Growth Rate (2014-2019)
Figure Global Imrecoxib Revenue Growth Rate (2014-2019)
Figure Global Etodolac Revenue Growth Rate (2014-2019)
Figure Global Parecoxib Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue by Application (2014-2019)
Table Global Selective Cox-2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Share by Application (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue Share by Application in 2018
Table Global Selective Cox-2 Inhibitors Revenue Forecast by Application (2019-2024)
Figure Global Selective Cox-2 Inhibitors Market Share Forecast by Application (2019-2024)
Figure Global Rheumatoid Arthritis Revenue Growth Rate (2014-2019)
Figure Global Osteoarthritis Revenue Growth Rate (2014-2019)
Figure Global Spondylosis Chronica Ankylopoietica Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Selective Cox-2 Inhibitors Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Selective Cox-2 Inhibitors Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Selective Cox-2 Inhibitors Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Europe Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure South America Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Selective Cox-2 Inhibitors Revenue Market Forecast (2019-2024)

Global Selective Agonists Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5100 2019年7月 136Pages
本調査レポートは、選択的アゴニストの世界市場について調べ、まとめました。種類別セグメントは、α1選択的アゴニスト、α2選択的アゴニスト、β1選択的アゴニスト、β2選択的アゴニスト等、用途別セグメントは、等に区分しました。選択的アゴニストの世界市場概観、企業動向、企業別選択的アゴニストシェア、市場規模...

選択的レーザー焼結（SLS）プリンターの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Selective Laser Sintering (SLS) Printers Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5103 2019年8月 135Pages
本調査レポートは、選択的レーザー焼結（SLS）プリンターの世界市場について調べ、まとめました。種類別セグメントは、固体レーザー、ガスレーザー等、用途別セグメントは、自動車、航空宇宙、消費財、機械設備、アート及びファッション、医療機器、その他等に区分しました。選択的レーザー焼結（SLS）プリンターの世...

硫黄選択検出器の世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Sulfur Selective Detector Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5578 2019年8月 122Pages
本調査レポートは、硫黄選択検出器の世界市場について調べ、まとめました。種類別セグメントは、硫黄化学発光検出器（SCD）、フレーム光度検出器（FPD）、質量分析検出器（MSD）、原子発光検出（AED）等、用途別セグメントは、炭化水素基質、天然ガス、軽油、残留燃料、その他等に区分しました。硫黄選択検出器...

選択的コンプライアンスアセンブリロボットアーム（SCARA）ロボットの世界市場予測 2019年：メーカー別、地域別、種類・用途別（～2024）

Global Selective Compliance Assembly Robot Arm (SCARA) Robots Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
B-GIR08C5101 2019年8月 122Pages
本調査レポートは、選択的コンプライアンスアセンブリロボットアーム（SCARA）ロボットの世界市場について調べ、まとめました。種類別セグメントは、シングルアームスカラ、デュアルアームスカラ等、用途別セグメントは、産業用、医療用、その他等に区分しました。選択的コンプライアンスアセンブリロボットアーム（S...

世界のCox-2阻害剤市場：市場規模・現状・予測

Global Cox-2 Inhibitors Market Size, Status and Forecast 2019-2025
QYR9N7036 2019年6月14日 99Pages
当資料は、Cox-2阻害剤のグローバル市場について調査・分析したレポートで、種類別（選択的Cox-2阻害剤、非選択的Cox-2阻害剤）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含ま...

乳がんCDK4 / 6阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global CDK4/6 Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C1129 2019年7月 116Pages
本調査レポートは、乳がんCDK4 / 6阻害剤の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、子供、大人等に区分しました。乳がんCDK4 / 6阻害剤の世界市場概観、企業動向、企業別乳がんCDK4 / 6阻害剤シェア、市場規模推移、市場規模予測（2019年-2024...

乳がんPARP阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global PARP Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4300 2019年8月 104Pages
本調査レポートは、乳がんPARP阻害剤の世界市場について調べ、まとめました。種類別セグメントは、オラパリブ、タラゾパリブ等、用途別セグメントは、携帯電話アクセサリー店、3C小売店、個人等に区分しました。乳がんPARP阻害剤の世界市場概観、企業動向、企業別乳がんPARP阻害剤シェア、市場規模推移、市場...

多発性骨髄腫プロテアソーム阻害薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Proteasome Inhibitors for Multiple Myeloma Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C4758 2019年8月 109Pages
本調査レポートは、多発性骨髄腫プロテアソーム阻害薬の世界市場について調べ、まとめました。種類別セグメントは、ボルテゾミブ、カルフィルゾミブ、イキサゾミブ、その他等、用途別セグメントは、ものづくり、ヘルスケア、輸送、情報通信、エネルギー・ユーティリティ、その他等に区分しました。多発性骨髄腫プロテアソー...

乳がん用アロマターゼ阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Aromatase Inhibitors for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C0374 2019年7月 124Pages
本調査レポートは、乳がん用アロマターゼ阻害剤の世界市場について調べ、まとめました。種類別セグメントは、等、用途別セグメントは、オートバイ、乗用車、LCV、HCV等に区分しました。乳がん用アロマターゼ阻害剤の世界市場概観、企業動向、企業別乳がん用アロマターゼ阻害剤シェア、市場規模推移、市場規模予測（2...

NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

Global Targeted Drug MEK Inhibitors for NSCLC Market 2019 by Company, Regions, Type and Application, Forecast to 2024
B-GIR08C5672 2019年7月 109Pages
本調査レポートは、NSCLC用標的薬物MEK阻害剤の世界市場について調べ、まとめました。種類別セグメントは、トラメチニブ、その他等、用途別セグメントは、等に区分しました。NSCLC用標的薬物MEK阻害剤の世界市場概観、企業動向、企業別NSCLC用標的薬物MEK阻害剤シェア、市場規模推移、市場規模予測...

世界のCox-2阻害剤市場：市場規模・現状・予測 Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins.In 2018, the global Cox-2 Inhibitors market size was …
イオン選択透過性樹脂市場：世界及び中国市場分析・予測（～2024年） Ion Selective Permeation Resin Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Ion Selective Permeation Resin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ion Sele…
選択的レーザー溶融機市場：世界及び中国市場分析・予測（～2024年） Selective Laser Melting Machines Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Selective Laser Melting Machines industry with a focus on the Chinese market. The report provides key statistics on the market status of the Sele…
選択的アゴニストの世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Selective Agonists market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also f…
NSCLC用標的薬物MEK阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global Targeted Drug MEK Inhibitors for NSCLC market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especia…